Northern Light Venture Capital
Overview
Northern Light Venture Capital (NLVC) is a leading venture capital firm specializing in early-stage enterprise technology, healthcare, and consumer technology companies. With $4.5 billion in capital under management, more than 300 investments and over 50 successful exits, NLVC partners with global entrepreneurs seeking global expansion opportunities, and helps build great, sustainable global companies that change society. NLVC is led by experienced entrepreneurs, operators, and investors with deep technical and global expertise.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vibrant Therapeutics | Jan 2026 | Early Funding | Co-investor |
| Spiro Medical, Inc. | Jan 2026 | Series A | Co-investor |
| Spiro Medical | Jan 2026 | Series A | Co-investor |
| Sanegene Bio | Dec 2025 | Series B | Co-investor |
| Kind Pharmaceuticals | Nov 2025 | Series C | Co-investor |
Key People
Jeffrey L.
Co-Founder
Bin Li
Operating Partner
Vivian Infan. Lee
Venture Partner
Figo Zhang
Partner
Fiona Yu
Partner
He HUANG
Partner
Lu lin
Partner
吴锋 wufeng
Partner
Fabio Jaco
Investor
Zhanjie Ma
Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.